Eli Lilly to expand pain pipeline with $1bn SiteOne buyout
Eli Lilly has agreed to acquire privately held biopharma company SiteOne Therapeutics, adding a non-opioid-based pain treatment to the big…
News
Capitalising on UK’s goal to become a world-leading clinical trial destination
GSK makes new drug submission for depemokimab in Canada
What’s been agreed at this year’s World Health Assembly?
Lupin partners SteinCares to commercialise biosimilar in LATAM
FDA to review Otsuka’s sibeprenlimab application for IgAN
EMA validates Soleno’s application for Prader-Willi syndrome treatment
China’s CDE grants breakthrough status approval to Abbisko’s HCC therapy
